[Skip to content]

.

Many children still at risk from measles, mumps and rubella infection

29 February 2008

Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) in the UK and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study
BMJ Editorial: Improving uptake of MMR vaccine


A large study of children born 2000-2002 in the UK found that not enough of them were being immunised against measles, mumps and rubella to ensure adequate control of the diseases. Researchers at the UCL Institute of Child Health and Great Ormond Street Hospital for Children found that 88.6% of children had been immunised with MMR by the age of three. 5.2% had received at least one of the single vaccines, and 6.1% were unimmunised. Of the 634 children who had received at least one single vaccine, just over half (52%) had received all three. The study published on bmj.com today emphasised that this was well below the level needed to prevent outbreaks of the diseases.  Although uptake of MMR vaccine has increased recently, there have been more cases of measles in 2007 than in any year for the past decade so further improvement is essential.  

The combined measles, mumps and rubella vaccine (MMR) was introduced in 1988 in the UK. Following the publication of unsubstantiated research in 1998, which was interpreted as suggesting a link between the vaccine and autism and bowel disease, uptake in England fell from 92% in 1995 to 79% in 2003.

The UCL researchers explored social, economic and cultural factors associated with uptake as well as parents’ reasons for not having MMR vaccine for the 14,578 children in the study. Children who had not received any MMR vaccine were more likely to come from a large family, their mother was more likely to smoke, and was either younger (under 20) or older (over 34) than average when she gave birth. In contrast they found that parents who chose single vaccines were significantly more likely to be white, well educated, affluent, older, and have just one child compared with parents who fully immunised their child.  Of the parents who chose not to have their child immunised with the MMR vaccine, the researchers report that nearly three quarters (74.4%) said it was due to a “conscious decision.” Common reasons given were being too scared, thinking the vaccine was too dangerous, links with autism, and negative media attention.

Although MMR uptake in this study is high, say the authors, a substantial proportion of children remain susceptible to avoidable infection, largely because parents consciously decide not to immunise.

They conclude, as does the accompanying editorial,  that to achieve the best possible control of vaccine preventable diseases, a variety of  measures may be required to target the different groups where uptake of the vaccine is low. 

Notes to Editors

This study only looked at uptake of the first dose of MMR vaccine. We know from other data that uptake of the second dose is much lower. This second dose is necessary to ensure all children are adequately protected.

Single antigen vaccines are not licensed for use in this country and are not a good substitute for the combined MMR vaccine. They are only available on a private basis.

This study is based on data from the Millennium Cohort Study, a longitudinal study of children born in the UK from September 2000 to January 2002. At three years, researchers determined MMR uptake and parents’ reasons for not opting for MMR.

The Millennium Cohort Study is funded by grants to Professor Heather Joshi, director of the study, from the ESRC and a consortium of government funders. This work received funding from the Department of Health and was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.

Contact:
Helen Bedford, Senior Lecturer, Centre for Paediatric Epidemiology and Biostatistics, UCL Institute of Child Health, London, UK 

David Elliman Consultant in Community Child Health

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Islington PCT and Great Ormond Street Hospital

Contact information:

GOSH-ICH Press Office: 020 7239 3125
Email: Coxs@gosh.nhs.uk
For genuine and urgent out of hours call speak to switchboard on 020 7405 9200

Notes to editors

High quality information on immunisation is on www.immunisation.nhs.uk

Great Ormond Street Hospital for Children NHS Trust is the country’s leading centre for treating sick children, with the widest range of specialists under one roof.

With the UCL Institute of Child Health, we are the largest centre for paediatric research outside the US and play a key role in training children’s health specialists for the future.

Our charity needs to raise £50 million every year to help rebuild and refurbish Great Ormond Street Hospital, buy vital equipment and fund pioneering research. With your help we provide world class care to our very ill children and their families.